Pyrido[3, 4-d]pyrimidine derivative and pharmaceutically acceptable salt thereof

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 11084814
SERIAL NO

16463458

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The purpose of the present invention is to provide a compound that has excellent CDK4/6 inhibitory activity. The present invention is a compound represented by formula (I) or a pharmaceutically acceptable salt of the compound.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
TEIJIN LIMITEDOSAKA 530-0005

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Horie, Kyohei Tokyo, JP 4 4
Maruyama, Akinobu Tokyo, JP 7 5
Mizuno, Tsuyoshi Tokyo, JP 34 206
Sakai, Yuri Tokyo, JP 10 221
Sasaki, Kosuke Tokyo, JP 30 238
Shimada, Tomohiro Tokyo, JP 21 73
Takahashi, Hiroshi Tokyo, JP 866 11944
Unoki, Gen Tokyo, JP 13 105
Yokosaka, Takuya Tokyo, JP 3 4

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
3.5 Year Payment $1600.00 $800.00 $400.00 Feb 10, 2025
7.5 Year Payment $3600.00 $1800.00 $900.00 Feb 10, 2029
11.5 Year Payment $7400.00 $3700.00 $1850.00 Feb 10, 2033
Fee Large entity fee small entity fee micro entity fee
Surcharge - 3.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00